awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34521260-243B7694-62A3-4FF1-BD0F-0BBD91CC9AFC
Q34521260-243B7694-62A3-4FF1-BD0F-0BBD91CC9AFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34521260-243B7694-62A3-4FF1-BD0F-0BBD91CC9AFC
A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma.
P2860
Q34521260-243B7694-62A3-4FF1-BD0F-0BBD91CC9AFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34521260-243B7694-62A3-4FF1-BD0F-0BBD91CC9AFC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bd5c1c72aa6ebb81eb366a75c0ecaaddf4ce3eb3
P2860
Multicenter randomized phase II study of weekly or twice-weekly bortezomib plus rituximab in patients with relapsed or refractory follicular or marginal-zone B-cell lymphoma.